Daré Bioscience, Inc.
DARE
$1.85
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.40M | -17.46M | -18.60M | -1.68M | -4.05M |
| Total Depreciation and Amortization | 1.63M | 1.11M | 634.30K | 189.60K | 42.30K |
| Total Amortization of Deferred Charges | 0.00 | 114.00K | -10.30K | 16.80K | 0.00 |
| Total Other Non-Cash Items | 2.09M | 2.44M | 2.53M | 2.65M | 3.59M |
| Change in Net Operating Assets | -210.70K | 7.78M | 3.94M | 5.64M | 5.89M |
| Cash from Operations | -9.89M | -6.02M | -11.51M | 6.82M | 5.47M |
| Capital Expenditure | -385.20K | -741.40K | -284.40K | -723.00K | -573.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -385.20K | -741.40K | -284.40K | -723.00K | -573.00K |
| Total Debt Issued | 486.70K | 486.70K | 561.70K | 561.70K | 561.70K |
| Total Debt Repaid | -1.82M | -1.48M | -1.02M | -566.00K | -579.20K |
| Issuance of Common Stock | 20.93M | 19.71M | 966.70K | 674.70K | 453.60K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -321.70K | -79.60K | -80.00K | -83.30K | -81.50K |
| Cash from Financing | 19.28M | 18.64M | 427.90K | 587.10K | 354.50K |
| Foreign Exchange rate Adjustments | 7.20K | -33.30K | -17.30K | -15.60K | -67.90K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.01M | 11.84M | -11.38M | 6.66M | 5.19M |